Oct 1, 2026 04:01PM
Oct 1, 2026 04:01PM
Aug 19, 2026 04:01PM
Aug 14, 2026 08:00AM
Aug 10, 2026 08:01AM
Aug 10, 2026 08:00AM
Aug 7, 2026 06:26AM Wedbush Upgrades Replimune Group (REPL) to Outperform
Aug 6, 2026 04:00PM
Aug 6, 2026 04:00PM
Aug 6, 2026 03:59PM
Aug 4, 2026 03:43AM
Jul 31, 2026 06:47AM
Jul 31, 2026 03:54AM
Jul 30, 2026 06:15PM FDA advisory panel votes 10-3 in favor of Replimune's melanoma drug
Jul 30, 2026 06:15PM
Jul 28, 2026 07:40AM
Jul 28, 2026 07:34AM
Jun 30, 2026 04:04AM
Jun 29, 2026 08:00AM
Jun 26, 2026 08:01AM
Jun 26, 2026 08:00AM Replimune Announces FDA Acceptance of RP1 Biologics License Application Resubmission for Advanced Melanoma
Jun 1, 2026 02:53AM
Jun 1, 2026 01:06AM
May 31, 2026 08:00AM
May 30, 2026 08:00AM
May 29, 2026 08:01AM
May 29, 2026 08:00AM
May 12, 2026 12:50PM FDA Commissioner Marty Makary is resigning - Politico reporter on X
May 8, 2026 01:32PM
Apr 27, 2026 08:00AM
Apr 13, 2026 03:41AM
Apr 13, 2026 01:54AM
Apr 10, 2026 05:04PM
Apr 10, 2026 05:02PM
Apr 10, 2026 04:16PM Cantor Fitzgerald Downgrades Replimune Group (REPL) to Neutral
Apr 10, 2026 01:20PM
Apr 10, 2026 11:19AM
Feb 3, 2026 08:00AM
Nov 12, 2025 07:43AM
Nov 7, 2025 04:45PM
Nov 7, 2025 04:45PM
Nov 6, 2025 08:00AM Replimune Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update
Nov 3, 2025 12:04AM
Oct 27, 2025 06:44AM
Oct 20, 2025 10:20AM
Oct 20, 2025 08:59AM
Oct 20, 2025 07:02AM
Oct 20, 2025 07:00AM
Oct 19, 2025 08:00AM Replimune Highlights Acral Melanoma Data for RP1 plus Nivolumab at the ESMO Congress 2025
Sep 19, 2025 06:51AM

334,273 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All